Ceftazidime/avibactam versus standard-of-care agents against carbapenem-resistant Enterobacteriaceae harbouring blaKPC in a one-compartment pharmacokinetic/pharmacodynamic model [PDF]
, 2018 Katie E. Barber +4 more
openalex +1 more source
518. Comparing the Mortality of Carbapenemase-Producing and Non-Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae Bacteremia [PDF]
, 2019 Hyeonji Seo +15 more
openalex +1 more source
Gut Microbiome-Based Strategies for the Control of Carbapenem-Resistant Enterobacteriaceae. [PDF]
J Microbiol BiotechnolLee I, Kim BS, Suk KT, Lee SS.
europepmc +1 more source
Estimating the Size of the U.S. Market for New Antibiotics with Activity against Carbapenem-Resistant Enterobacteriaceae [PDF]
, 2019 Cornelius J. Clancy, M. Hong Nguyen
openalex +1 more source
Molecular Characterization of Class 1 Integrons in Carbapenem-Resistant Enterobacteriaceae Isolates
, 2022 tong wang +4 more
openalex +1 more source
Carbapenem-resistant Enterobacteriaceae: What we know and what we need to know
van Duin D.
openalex +1 more source
Molecular epidemiology of carbapenem resistant Enterobacteriaceae in Sri Lanka: First report of KPC-producing Klebsiella pneumoniae [PDF]
, 2019 Wirittamulla Gamage Maheshika Kumudunie +4 more
openalex +1 more source
Drug Resistance and Epidemiological Analysis of Carbapenem-Resistant Enterobacteriaceae in a Brain and Psychiatric Hospital of South China. [PDF]
J Clin Lab AnalYue L, Zhu X, Kuang Y, Lin Y, Liu H.
europepmc +1 more source
The Comparative Efficacy of Ceftazidime-Avibactam with or without Aztreonam vs Polymyxins for Carbapenem-resistant Enterobacteriaceae Infections: A Prospective Observational Cohort Study. [PDF]
Indian J Crit Care Med, 2023 Vijayakumar M +3 more
europepmc +1 more source